Treat obstructive sleep apnea
with one pill
before bedtime
Our Mission
Our mission is to provide safe and effective solutions that improve the health and quality of life of patients with obstructive sleep apnea. Our goal is to provide better sleep, better health, and better dreams.
Somnia Therapeutics is a patient-centric biotechnology company developing an oral therapy for the treatment of obstructive sleep apnea (OSA), a widespread public health issue affecting more than 10% of adult Americans.
Current treatments are uncomfortable and/or invasive, resulting in low patient compliance or adoption, leaving the majority of patients untreated. At Somnia, we are taking an innovative approach to this largely unmet medical need, providing an easily adaptable and accessible treatment — taking a pill at bedtime.
our team
Somnia’s team consists of scientists, physicians, experienced biotech pharmaceutical entrepreneurs, and patients. We have experience in the successful discovery and development of several FDA-approved drugs. We are passionate about developing therapies for unmet medical needs for patients.
